Brand versus Generic Rosuvastatin in Egyptian Patients with Hyperlipidemia; Cost-Minimization Analysis

Journals Menu

Follow SCIRP

ISSN Print: 2158-284X
ISSN Online: 2158-2882
www.scirp.org/journal/ijcm
E-mail: ijcm@scirp.org

"Brand versus Generic Rosuvastatin in Egyptian Patients with Hyperlipidemia; Cost-Minimization Analysis"
written by Sameh Shaheen, Ahmed S. H. Elserafy, Mohamed Amin, Ramy Hassan, Emad R. Issak,
published by International Journal of Clinical Medicine, Vol.10 No.12, 2019

has been cited by the following article(s):

[1]	Проблема выбора: оригинальный препарат или дженерик? Акцент на розувастатин
	… фармакотерапия в кардиологии, 2022

[2]	The burden of obesity in Egypt
	Frontiers in public …, 2021

Follow SCIRP

[1]	The problem of choice: original drug or generic? Emphasis on rosuvastatin Rational Pharmacotherapy in Cardiology, 2022 DOI:10.20996/1819-6446-2022-04-10

[2]	The Burden of Obesity in Egypt Frontiers in Public Health, 2021 DOI:10.3389/fpubh.2021.718978